CPC technology class · G16
G16C - Computational Chemistry
Computational chemistry; chemoinformatics; computational materials science. 1,640 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.
- 1,640
- US patents granted
- #5/5
- in G16
- 2.9%
- G16 class share
- +64%
- 5-yr velocity
The verdict
According to USPTO PatentsView, Computational Chemistry ranks #394 of 670 CPC technology areas - 1,640 US patents granted since 2015, with recorded grant volume up 64% over five years.
- #394
- of 670 CPC technology areas
- 1,640
- US patents granted, 2015–2025
- International Business…
- leading assignee (78)
- +64%
- grant velocity, last 5 yrs
How G16C's grant cadence moved
Between 2020–2024, G16C recorded 861 grants versus 524 in 2015–2019 (+64% equal-window velocity). Across complete years, output peaked in 2024 at 209 grants and bottomed in 2015 at 75 (+179% peak-over-trough). Lead assignee Shimadzu Corporation holds 1.8% of the class ; the top three share 4.5%.
Leaderboard read
G16C concentration, lead at 1.8%
Shimadzu Corporation leads this historical grant record at 1.8% of G16C - us corporation assignees hold 55% of class grants (313 of 564). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.
- Leader's share
- 1.8%
- Top three share
- 4.5%
- Lead over #2
- 5
30 of 1,640 grants
of the class's recorded grants
more grants than DH Technologies Development PTE. Ltd.
Where G16C sits inside G16
Among 5 subclasses in G16 (Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields), G16C ranks #5 and holds 2.9% of the parent class's 56,268 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.
Rising assignees active in G16C
Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.
- #1 Waters Technologies Ireland Limited 24x 1 → 24 company-wide · 9 in G16C
- #2 Peptilogics, Inc. 10x 1 → 10 company-wide · 8 in G16C
- #3 RO5 Inc. 6.00x 2 → 12 company-wide · 8 in G16C
- #4 Hangzhou Fujia Gallium Technology Co. Ltd. 6.00x 0 → 6 company-wide · 6 in G16C
- #5 Lunella Biotech, Inc. 4.75x 4 → 19 company-wide · 6 in G16C
G16C grants by year, peak 2024 (209)
US utility-patent grants per year in G16C, 2015–2025 - recent five years are up 64% versus 2015–2019.
Who leads G16C?
The 12 most active assignees in Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science - wider bars mean more grants
- Shimadzu
Shimadzu Corporation
30 patents
- Dh Development Pte
DH Technologies Development PTE. Ltd.
25 patents
- Tata Consultancy…
Tata Consultancy Services Limited
18 patents
- ubiome
uBiome, Inc.
17 patents
- Personalis
Personalis, Inc.
17 patents
- Perkinelmer Informatic…
PerkinElmer Informatics, Inc.
12 patents
- Recursion Pharmaceutic… 9
Recursion Pharmaceuticals, Inc.
9 patents
- Waters Ireland 9
Waters Technologies Ireland Limited
9 patents
- Shenzhen Jingtai… 9
Shenzhen Jingtai Technology Co., Ltd.
9 patents
- Schrödinger 9
Schrödinger, LLC
9 patents
- Synopsys 8
Synopsys, Inc.
8 patents
- Immatics Biotechnologi… 8
Immatics Biotechnologies GmbH
8 patents
What this shows International… is the most active filer in G16C, holding 78 of the 1,640 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in G16C |
|---|---|---|
| #1 | Shimadzu Corporation | 30 |
| #2 | DH Technologies Development PTE. Ltd. | 25 |
| #3 | Tata Consultancy Services Limited | 18 |
| #4 | uBiome, Inc. | 17 |
| #5 | Personalis, Inc. | 17 |
| #6 | PerkinElmer Informatics, Inc. | 12 |
| #7 | Recursion Pharmaceuticals, Inc. | 9 |
| #8 | Waters Technologies Ireland Limited | 9 |
| #9 | Shenzhen Jingtai Technology Co., Ltd. | 9 |
| #10 | Schrödinger, LLC | 9 |
| #11 | Synopsys, Inc. | 8 |
| #12 | Immatics Biotechnologies GmbH | 8 |
| #13 | Thermo Fisher Scientific (BREMEN) GMBH | 8 |
| #14 | Insilico Medicine IP Limited | 8 |
| #15 | RO5 Inc. | 8 |
| #16 | Caris MPI, Inc. | 8 |
| #17 | Peptilogics, Inc. | 8 |
| #18 | Codexis, Inc. | 6 |
| #19 | Lunella Biotech, Inc. | 6 |
| #20 | Notco Delaware, LLC | 6 |
Footprint here vs. claim strategy
Each dot is a leading G16C assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Classes near G16C's 1,640-grant footprint
Nationwide nearest neighbors for G16C (#394 of 670 by volume ; lead share 4.8%) - not the G16 parent-class siblings above.
Nearest by grant volume
Questions about G16C
Which company holds the most patents in G16C?
Which G16C assignees grew fastest recently?
How does G16C compare inside parent class G16?
What to do with this data
G16C in context - here's where to go next.
- Shimadzu Corporation leads G16C with 30 grants in this class. See full portfolio
- G16C ranks #394 of 670 by grant volume among all tracked CPC technology areas. See the ranking
- Inside parent class G16, the largest sibling subclass is G16H with 42,899 grants. Explore G16H
Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.
Methodology - G16C figures are USPTO PatentsView granted-utility totals for this subclass (1,640 grants in the tracked window).
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.